BioNordic A/S: Financial statements 2021
CVR: 40831622
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
BioNordic A/S (CVR 40831622) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 40,331,968 and a net result of DKK 408,202. Equity in the 2021 report amounted to DKK 18,210,543. The solvency ratio was 7.2%. The company had 84 employees in the financial year.
- Gross Profit
- DKK 40,331,968
- Profit/Loss
- DKK 408,202
- Equity
- DKK 18,210,543
- Total Assets
- DKK 252,629,085
- Employees
- 84
Official annual report
Find more companies like BioNordic A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 17, 2021, Jørn Martin Bank has joined the board of directors of BioNordic A/S.
As of December 16, 2021, Jørn Martin Bank has left the board of directors of BioNordic A/S.
BioNordic A/S has published its interim report for the period September 23, 2019 to December 31, 2020.
About BioNordic A/S
BioNordic A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Lene Ploug Bülow and Nicolas Bødtker Nielsen. The company's owners include Ole Bødtker Nielsen, Stefan Bødtker Michelsen and Nicolas Bødtker Nielsen. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 49,188,844 and a net result of DKK 131,702,212 compared with DKK -20,860,483 the year before. Equity in the 2025 report amounted to DKK 163,782,004.